Since Lundbeck went through a larger shift in its research and development division, the company has been busy scouting for assets that could fit in its new focus area, neuroinflammation or neuroimmunology.
This has resulted in the purchase of the phase I-ready antibody APB-A1 from the South Korean company Aprilbio, and Lundbeck's Head of Research and Development Johan Luthman is excited to finally have the first real candidate in the company's new area.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Coloplast could win big on Polish reimbursement changes
The Polish Ministry of Health has increased the reimbursement amount for hydrophilic catheters, which Coloplast supplies. The Danish medtech company calls the new scheme a "breakthrough."
Several positive elements in Eli Lilly Q3 report, says analyst
.jpg)
An analyst at Sydbank thinks that Eli Lilly's third quarter report includes a number of positive elements, and emphasizes that this could also be good news for competitor Novo Nordisk.
Eli Lilly upgrades earnings per share guidance
On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.
Cloud computing saves money and cuts carbon emissions at Novo Nordisk
Integrating cloud solutions has helped with Novo Nordisk's sustainable transition, Danish media reports.
Lundbeck chairman demands change: "We can't live with this"
Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
Data Analytics & Visualization Manager 
Nordic Field Sales Manager 
Senior Manager/Associate Director Regulatory Affairs 
QA Specialist wanted 
Clinical Trial Manager 
CMC Project Manager 
Software Developer, Cardiac Applications – Medical Devices, DK 
Laboratory assistant for research department 
Senior Validation Analyst, Zealand Pharma 
KLIFO is looking for a talented and committed Pharmacovigilance Associate based in Denmark 
Global Product Manager 
GxP QA Compliance Manager for Quality Assurance 
Director of Biostatistics 
Application Manager (GxP Systems) - Zealand Pharma